Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
50 participants
INTERVENTIONAL
2024-03-01
2027-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Transcranial Magnetic Stimulation to the Cerebellum on Cognition
NCT00740701
Neural Dynamics and Connectivity in Response Inhibition and Traumatic Brain Injury
NCT01194661
Cortical Contributions to Motor Sequence Learning
NCT04138953
Evaluation, Pathogenesis, and Outcome of Subjects With or Suspected Traumatic Brain Injury
NCT01132937
Evaluation of Outcome Measures for Patients Diagnosed With Traumatic Brain Injury
NCT01020318
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cerebellar Stimulation
TMS will be administered to the cerebellum on half the trials of a sequence-demanding task, and on half the trials of a non-sequence-demanding task. Task order will be counterbalanced.
TMS during sequence-demanding task
TMS is administered during the execution of sequence-demanding task. Transcranial magnetic stimulation (TMS) is a safe and non-invasive technique for transiently modulating brain activity
No TMS during sequence-demanding task
TMS is not administered during the execution of sequence-demanding task.
TMS during non-sequence-demanding task
TMS is administered during the execution of non-sequence-demanding task. Transcranial magnetic stimulation (TMS) is a safe and non-invasive technique for transiently modulating brain activity
No TMS during non-sequence-demanding task
TMS is not administered during the execution of non-sequence-demanding task
Occipital Stimulation
TMS will be administered to an occipital control region on half the trials of a sequence-demanding task, and on half the trials of a non-sequence-demanding task. Task order will be counterbalanced.
TMS during sequence-demanding task
TMS is administered during the execution of sequence-demanding task. Transcranial magnetic stimulation (TMS) is a safe and non-invasive technique for transiently modulating brain activity
No TMS during sequence-demanding task
TMS is not administered during the execution of sequence-demanding task.
TMS during non-sequence-demanding task
TMS is administered during the execution of non-sequence-demanding task. Transcranial magnetic stimulation (TMS) is a safe and non-invasive technique for transiently modulating brain activity
No TMS during non-sequence-demanding task
TMS is not administered during the execution of non-sequence-demanding task
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TMS during sequence-demanding task
TMS is administered during the execution of sequence-demanding task. Transcranial magnetic stimulation (TMS) is a safe and non-invasive technique for transiently modulating brain activity
No TMS during sequence-demanding task
TMS is not administered during the execution of sequence-demanding task.
TMS during non-sequence-demanding task
TMS is administered during the execution of non-sequence-demanding task. Transcranial magnetic stimulation (TMS) is a safe and non-invasive technique for transiently modulating brain activity
No TMS during non-sequence-demanding task
TMS is not administered during the execution of non-sequence-demanding task
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2\) educational attainment of at least 8 years;
* 3\) capable of giving informed consent;
* 4\) fluent speaker of English by self-report;
* 5\) right handed.
Exclusion Criteria
* 2\) neurological or systemic disorder which can cause dementia or cognitive dysfunction;
* 3\) history of an Axis I psychiatric disorder including substance use disorder;
* 4\) history of definite stroke;
* 5\) focal lesion on MRI exam;
* 6\) uncorrected visual deficits by self-report
* 7\) contraindications for MRI scanning
* 8\) use of anxiolytic, antidepressant, neuroleptic, or sedative medication
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
Johns Hopkins University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John E Desmond, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Johns Hopkins University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
John E. Desmond, Ph.D.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00328214
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.